We were able to reduce the circulation-supporting medication and we saw decreasing lacatate levels and the patient was more stable.
Prof. Hamzaoui shares a compelling summary of key highlights, clinical insights, and the growing role of CytoSorb Therapy in critical care.
I can speak about a case where the patient had acute chronic liver failure in the context of known liver cirrhosis.
